Burden of gastric and digestive cancers in the French Caribbean: perspectives from population-based cancer registries of Martinique, Guadeloupe and French Guiana (2007-2014).
epidemiology
gastroenterology
oncology
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
02 02 2022
02 02 2022
Historique:
entrez:
3
2
2022
pubmed:
4
2
2022
medline:
23
3
2022
Statut:
epublish
Résumé
Data from population-based cancer registries contribute to improving our knowledge of digestive cancer trends worldwide. In this study, we present cancer incidence and mortality in Guadeloupe, French Guiana and Martinique for the periods 2008-2014, 2010-2014 and 2007-2014, respectively. Data were extracted from population-based cancer registries. World-standardised incidence (WSI) and mortality (WSM) rates were calculated. Main digestive cancers were analysed, including oesophagus, stomach, colorectum, liver and pancreas cancers. This study was performed based on data from French Territories in the Caribbean. We observed a lower-incidence compared with mainland France, except for stomach cancer for which the incidence is high, with significant standardised incidence ratios in men and women at 1.90 vs 2.29 for Guadeloupe and French Guiana and 1.58 vs 2.31 for Martinique. We found a lower-mortality, except for stomach cancer for which the mortality remains high, with significant mortality ratios in men and women at 2.10 vs 2.74 for Guadeloupe, 1.64 vs 1.79 for French Guiana and 2.05 vs 2.53 for Martinique. Overall, these three regions have similar WSI and WSM rates which remain lower than those in mainland France. We noticed an overall high incidence and high mortality in men compared with women as in France. There is a high incidence of stomach cancer in French overseas territories. Publication of these data contributed to expanding knowledge on the epidemiology of world cancers with data from the Caribbean zone.
Identifiants
pubmed: 35110303
pii: bmjopen-2020-047167
doi: 10.1136/bmjopen-2020-047167
pmc: PMC8811555
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e047167Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13
pubmed: 24618998
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Cancer Epidemiol. 2017 Jun;48:85-91
pubmed: 28426981
Cancer Epidemiol. 2016 Apr;41:88-95
pubmed: 26851752
Biostatistics. 2019 Jul 1;20(3):452-467
pubmed: 29617897
Gastroenterology. 2018 Jan;154(2):360-373
pubmed: 28823862
Rev Epidemiol Sante Publique. 2014 Apr;62(2):95-108
pubmed: 24613140
Gut. 2015 Mar;64(3):381-7
pubmed: 25320104
Medicine (Baltimore). 2019 Aug;98(35):e16941
pubmed: 31464932
Cancer Epidemiol. 2019 Jun;60:141-148
pubmed: 31009922
Aliment Pharmacol Ther. 2014 Aug;40(3):250-60
pubmed: 24912650
N Engl J Med. 2011 Sep 22;365(12):1118-27
pubmed: 21992124
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
BMC Cancer. 2019 Mar 15;19(1):239
pubmed: 30876409
Rev Epidemiol Sante Publique. 2017 Jun;65(3):181-188
pubmed: 28185756
Int J Cancer. 2016 Oct 1;139(7):1534-45
pubmed: 27244487
Cancer Manag Res. 2018 Feb 07;10:239-248
pubmed: 29445300
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308